MY ACCOUNT | NEWSLETTER |

Sploot opens second clinic in Denver, with more on the way


Sploot Veterinary Care, founded in Denver in 2021, recently opened its second clinic in the Mile High City. The company also announced plans to open three additional locations in Denver by mid-2023, with 10 more clinics under development.

Sploot focuses on delivering convenient, pet-parent centric primary and urgent care, with the goal of offering 85%+ of care needs in one seamless, warm clinic experience, according to a news release.

In its first 10 months of operation, Sploot served over 10,000 pets across Denver.

"Today's pet parents - who treat their pets like family members - want what they're already experiencing elsewhere," said Gil Bolotin, co-founder of Sploot Veterinary Care in the news release. "They want convenience, excellent customer service, transparency. And that's what we provide at Sploot.

Three more locations are planned to open across the Denver area in 2023, and a total of 10 clinics are being developed.

"Every aspect of the Sploot experience is designed to provide an unparalleled care experience for pets and pet parents, whether it's the ease of booking online and tele-triage services available every day, or the fact that 95% of our pet parents can get same or next day appointments,” said Bolotin.

With its current and upcoming plans, Sploot intends to serve the entire metropolitan Denver area.

Yoav Mordowicz, co-founder of Sploot, said in an industry where burn out is a reality, the company is proud to have invested, from day one, in culture, career development and work life balance.

“If I had to point to one thing that's driving our growth, it's that - our people investment, and the team's resulting commitment to providing pets and pet parents with outstanding care," he said.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

World Veterinary Dermatology Day

Like0
Dislike0

Artificial insemination market to grow to $3B by 2028

Like0
Dislike0

February is National Pet Dental Health Month

Like0
Dislike0

Falling markets? Don't panic, it's not the first time

Like0
Dislike0

Treatment of canine chronic cutaneous lupus erythematosus with oclacitinib

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2023 - All Rights Reserved
ISSN 2768-198X

Top